Travere Therapeutics Inc (NAS:TVTX)
$ 6.16 -0.18 (-2.84%) Market Cap: 468.95 Mil Enterprise Value: 431.93 Mil PE Ratio: 0 PB Ratio: 6.33 GF Score: 54/100

Q4 2019 Retrophin Inc Earnings Call Transcript

Feb 24, 2020 / 09:30PM GMT
Release Date Price: $16.56 (-4.17%)
Operator

Good afternoon, ladies and gentlemen. And welcome to the Retrophin, Inc. Fourth Quarter Full Year 2019 Financial Results and Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Chris Cline. Please go ahead.

Chris Cline
Retrophin, Inc. - VP of IR & Corporate Communications

Great. Thank you, Angela. Good afternoon, everyone. And welcome to Retrophin's fourth quarter and full year 2019 financial results and corporate update call. Today's call will be led by our Chief Executive Officer, Dr. Eric Dube, and will be joined for the prepared remarks by our Chief Medical Officer, Dr. Noah Rosenberg; and our Chief Financial Officer, Laura Clague. Peter Heerma, our Chief Commercial Officer; and Dr. Bill Rote, Senior Vice President of Research and Development, will join us for the Q&A session.

Before we begin, I would like to remind everyone that statements made during this call regarding matters that are not historical facts are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot